Closed-loop insulin delivery - what lies between where we are and where we are going? (Q36316740)

13 August 2017

1 reference

title

Closed-loop insulin delivery - what lies between where we are and where we are going? (English)

1 reference

13 August 2017

Garry M Steil

1

1 reference

PubMed ID

16296759

13 August 2017

Kerstin Rebrin

series ordinal

2

1 reference

PubMed ID

16296759

13 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Drug Delivery

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

353-362

1 reference

13 August 2017

2

1 reference

Type 1 diabetes: recent developments

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Regulation of insulin secretion: insights from engineered beta-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Harnessing the Immunomodulatory Properties of Sertoli Cells to Enable Xenotransplantation in Type I Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Glucose sensors: toward closed loop insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Physiological differences between interstitial glucose and blood glucose measured in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Models of subcutaneous insulin kinetics. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Assessment of insulin sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

The intravenous route to blood glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

The subcutaneous route to insulin-dependent diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Closed-loop insulin delivery-the path to physiological glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Basal hepatic glucose production is regulated by the portal vein insulin concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Direct and indirect effects of insulin on glucose uptake and storage by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

A mathematical model for the glucose induced insulin release in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Automated feedback control of subcutaneous glucose concentration in diabetic dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Control-relevant modeling in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Modeling of insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

British Diabetic Association Review of the AIDA v4 Diabetes Software Simulator Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Modeling insulin action for development of a closed-loop artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

Use of a novel triple-tracer approach to assess postprandial glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.353

21 January 2018

Identifiers

DOI

10.1517/17425247.2.2.353

1 reference

13 August 2017

1 reference

PubMed ID

16296759